Patent US4859779A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4859779A Expired / Lapsed US ⏱️ 0.0 years remaining

Dopamine-β-hydroxylase inhibitors

Assignee: SmithKline Beecham Corp
•
Filing: 1989-01-27
•
Granted: 1989-08-22
•
Expires: 2009-01-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Potent dopamine- beta -hydroxylase inhibitors having the formula <IMAGE> that are useful to inhibit dopamine- beta -hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine- beta -hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.

Inventors

  • 👤 Joseph A. Finkelstein
  • 👤 Lawrence I. Kruse
  • 👤 Thomas B. Leonard

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 07:45
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/66; C07D233/90

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 80 words
A compound represented by the formula: ##STR8## in which: X is H, F, Cl, Br, I, C 1-4 alkyl, CN, NO 2 , SO 2 NH 2 , COOH, OH, CHO, C 1-4 alkyl, CN, CF 3 , SO 2 CH 3 , SO 2 CF 3 , or CO 2 C a H 2a+1 wherein a is 1-5, or any accessible combination thereof of up to 5 substituents; R is hydrogen or C 1-4 alkyl; and n is 0-5.
Claim 2
Dependent Claim 80 words
A compound represented by the formula: ##STR8## in which: X is H, F, Cl, Br, I, C 1-4 alkyl, CN, NO 2 , SO 2 NH 2 , COOH, OH, CHO, C 1-4 alkyl, CN, CF 3 , SO 2 CH 3 , SO 2 CF 3 , or CO 2 C a H 2a+1 wherein a is 1-5, or any accessible combination thereof of up to 5 substituents; R is hydrogen or C 1-4 alkyl; and n is 0-5.
Claim 3
Dependent Claim 11 words
A compound as claimed in claim 1 being the compound N-(2-aminoethyl)-1-(3,5-difluorobenzyl)-2-mercaptoimidazole-5-carbozamide.
Claim 4
Dependent Claim 11 words
A compound as claimed in claim 1 being the compound N-(2-amino-n-butyl)-1-(3,5-difluorobenzyl)-2-mercaptoimidazole-5-carboxamide.

References Cited (Backward Citations)

US4532331A Cited
US4719223A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-08-21 1993-02-20 1993-08-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-08-21 1997-02-20 1997-08-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-08-21 2001-02-20 2001-08-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag